<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39448915</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>A conceptual health state diagram for modelling the transmission of a (re)emerging infectious respiratory disease in a human population.</ArticleTitle><Pagination><StartPage>1198</StartPage><MedlinePgn>1198</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1198</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-10017-8</ELocationID><Abstract><AbstractText>Mathematical modelling of (re)emerging infectious respiratory diseases among humans poses multiple challenges for modellers, which can arise as a result of limited data and surveillance, uncertainty in the natural history of the disease, as well as public health and individual responses to outbreaks. Here, we propose a COVID-19-inspired health state diagram (HSD) to serve as a foundational framework for conceptualising the modelling process for (re)emerging respiratory diseases, and public health responses, in the early stages of their emergence. The HSD aims to serve as a starting point for reflection on the structure and parameterisation of a transmission model to assess the impact of the (re)emerging disease and the capacity of public health interventions to control transmission. We also explore the adaptability of the HSD to different (re)emerging diseases using the characteristics of three respiratory diseases of historical public health importance. We outline key questions to contemplate when applying and adapting this HSD to (re)emerging infectious diseases and provide reflections on adapting the framework for public health-related interventions.</AbstractText><CopyrightInformation>© 2024. Crown.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avramov</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biology, Carleton University, 1125 Colonel By Drive, Ottawa, ON, K1S 5B6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ottawa Research and Development Centre, Agriculture and Agri-Food Canada, 960 Carling Avenue, Ottawa, ON, K1A 0C6, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique, Faculté de Médecine Vétérinaire, Université de Montréal, 3190 Rue Sicotte, Saint-Hyacinthe, QC, J2S 2M1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabriele-Rivet</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique, Faculté de Médecine Vétérinaire, Université de Montréal, 3190 Rue Sicotte, Saint-Hyacinthe, QC, J2S 2M1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milwid</LastName><ForeName>Rachael M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique, Faculté de Médecine Vétérinaire, Université de Montréal, 3190 Rue Sicotte, Saint-Hyacinthe, QC, J2S 2M1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogden</LastName><ForeName>Nicholas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique, Faculté de Médecine Vétérinaire, Université de Montréal, 3190 Rue Sicotte, Saint-Hyacinthe, QC, J2S 2M1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hongoh</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Public Health Risk Sciences Division, Scientific Operations and Response, National Microbiology Laboratory Branch, Public Health Agency of Canada, 3200 Rue Sicotte, C.P. 5000, Saint-Hyacinthe, QC, J2S 2M2, Canada. valerie.hongoh@phac-aspc.gc.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique, Faculté de Médecine Vétérinaire, Université de Montréal, 3190 Rue Sicotte, Saint-Hyacinthe, QC, J2S 2M1, Canada. valerie.hongoh@phac-aspc.gc.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="Y">Communicable Diseases, Emerging</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emerging disease</Keyword><Keyword MajorTopicYN="N">Epidemic</Keyword><Keyword MajorTopicYN="N">Mathematical modelling</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Reemerging disease</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>1</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39448915</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-10017-8</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-10017-8</ArticleId><ArticleId IdType="pmc">PMC11515510</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ng V, Fazil A, Waddell LA, Bancej C, Turgeon P, Otten A, et al. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada. Can Med Assoc J. 2020;192(37):E1053-64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7513947</ArticleId><ArticleId IdType="pubmed">32778573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludwig A, Berthiaume P, Orpana H, Nadeau C, Diasparra M, Barnes J, et al. Assessing the impact of varying levels of case detection and contact tracing on COVID-19 transmission in Canada during lifting of restrictive closures using a dynamic compartmental model. Can Commun Dis Rep. 2020;46(1112):409–21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799879</ArticleId><ArticleId IdType="pubmed">33447163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherratt K, Carnegie AC, Kucharski A, Cori A, Pearson CAB, Jarvis CI, et al. Improving modelling for epidemic responses: reflections from members of the UK infectious disease modelling community on their experiences during the COVID-19 pandemic. Wellcome Open Res. 2024;9:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11112301</ArticleId><ArticleId IdType="pubmed">38784437</ArticleId></ArticleIdList></Reference><Reference><Citation>Medley GF. A consensus of evidence: the role of SPI-M-O in the UK COVID-19 response. Adv Biol Regul. 2022;86:100918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9525209</ArticleId><ArticleId IdType="pubmed">36210298</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrin T, Ayache D, Baumeister A, Young K, Pussegoda K, Ahmad R, et al. COVID-19 literature surveillance—a framework to manage the literature and support evidence-based decision-making on a rapidly evolving public health topic. Can Commun Dis Rep. 2023;49(1):5–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9902036</ArticleId><ArticleId IdType="pubmed">36815866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA, Cripps S, Tanner MA. Forecasting for COVID-19 has failed. Int J Forecast. 2022;38(2):423–38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7447267</ArticleId><ArticleId IdType="pubmed">32863495</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauer F, Castillo-Chavez C, Feng Z. Models for influenza. In: Mathematical models in epidemiology. New York: Springer New York; 2019. p. 311–50. (Texts in Applied Mathematics; vol. 69). Available from: http://link.springer.com/10.1007/978-1-4939-9828-9_9. Cited 2024 Mar 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9828-9_9</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem K, Cook AR, Jit M. Projecting social contact matrices in 152 countries using contact surveys and demographic data . Halloran B, editor. PLOS Comput Biol. 2017;13(9):e1005697.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5609774</ArticleId><ArticleId IdType="pubmed">28898249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia N, Tsui L. Epidemic modelling using Sars as a case study. North Am Actuar J. 2005;9(4):28–42.</Citation></Reference><Reference><Citation>MacIntyre CR. The discrepant epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV). Environ Syst Decis. 2014;34(3):383–90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7104603</ArticleId><ArticleId IdType="pubmed">32288979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci. 2004;101(16):6146–51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC395937</ArticleId><ArticleId IdType="pubmed">15071187</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery MP, Morris SE, Rolfes MA, Kittikraisak W, Samuels AM, Biggerstaff M, et al. The role of asymptomatic infections in influenza transmission: what do we really know. Lancet Infect Dis. 2023;24(6):e394–e404. 10.1016/S1473-3099(23)00619-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11127787</ArticleId><ArticleId IdType="pubmed">38128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Regoes RR, Bonhoeffer S. Emergence of drug-resistant influenza virus: population dynamical considerations. Science. 2006;312(5772):389–91.</Citation><ArticleIdList><ArticleId IdType="pubmed">16627735</ArticleId></ArticleIdList></Reference><Reference><Citation>Stilianakis NI, Perelson AS, Hayden FG. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. J Infect Dis. 1998;177(4):863–73.</Citation><ArticleIdList><ArticleId IdType="pubmed">9534957</ArticleId></ArticleIdList></Reference><Reference><Citation>Asplin P, Keeling MJ, Mancy R, Hill EM. Epidemiological and health economic implications of symptom propagation in respiratory pathogens: a mathematical modelling investigation. Lam TTY, editor. PLOS Comput Biol. 2024;20(5):e1012096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11095726</ArticleId><ArticleId IdType="pubmed">38701066</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Y, Jia Y, Chen L, Guo L, Shu B, Long E. COVID-19 epidemic prediction and the impact of public health interventions: a review of COVID-19 epidemic models. Infect Dis Model. 2021;6:324–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790451</ArticleId><ArticleId IdType="pubmed">33437897</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell TW, Golding N, Hellewell J, Abbott S, Wright L, Pearson CAB, et al. Reconstructing the early global dynamics of under-ascertained COVID-19 cases and infections. BMC Med. 2020;18(1):332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577796</ArticleId><ArticleId IdType="pubmed">33087179</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172(9):577–82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7081172</ArticleId><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. Lancet Infect Dis. 2020;20(5):553–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158569</ArticleId><ArticleId IdType="pubmed">32171059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Suarez C, Murillo-Zamora E. Waning immunity to SARS-CoV-2 following vaccination or infection. Front Med. 2022;9: 972083.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9606629</ArticleId><ArticleId IdType="pubmed">36313998</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad-Roy CM, Morris SE, Boots M, Baker RE, Lewis BL, Farrar J, et al. Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy. Wallqvist A, editor. PLOS Comput Biol. 2024;20(8):e1012211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11299835</ArticleId><ArticleId IdType="pubmed">39102402</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelov G, Kovacevic R, Stilianakis NI, Veliov VM. An immuno-epidemiological model with waning immunity after infection or vaccination. J Math Biol. 2024;88(6). Available from: https://link.springer.com/10.1007/s00285-024-02090-z. Cited 2024 Sep 17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00285-024-02090-z</ArticleId><ArticleId IdType="pmc">PMC11052727</ArticleId><ArticleId IdType="pubmed">38668894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee LE, Fua T, Chua YY, Ho AFW, Sim XYJ, Conceicao EP, et al. Containing COVID-19 in the emergency department: the role of improved case detection and segregation of suspect cases. Kline JA, editor. Acad Emerg Med. 2020;27(5):379–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262126</ArticleId><ArticleId IdType="pubmed">32281231</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MA, Atangana A, Alzahrani E, Fatmawati. The dynamics of COVID-19 with quarantined and isolation. Adv Differ Equ. 2020;2020(1):425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427274</ArticleId><ArticleId IdType="pubmed">32834821</ArticleId></ArticleIdList></Reference><Reference><Citation>Tupper P, Otto SP, Colijn C. Fundamental limitations of contact tracing for COVID-19. Pai N, editor. FACETS. 2021;6:1993–2001.</Citation></Reference><Reference><Citation>Gurbaxani BM, Hill AN, Patel P. Unpacking Cochrane’s update on masks and COVID-19. Am J Public Health. 2023;113(10):1074–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10484132</ArticleId><ArticleId IdType="pubmed">37672741</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Taeihagh A, Tan SY. A scoping review of the impacts of COVID-19 physical distancing measures on vulnerable population groups. Nat Commun. 2023;14(1):599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9897623</ArticleId><ArticleId IdType="pubmed">36737447</ArticleId></ArticleIdList></Reference><Reference><Citation>Caulkins JP, Grass D, Feichtinger G, Hartl RF, Kort PM, Prskawetz A, et al. The optimal lockdown intensity for COVID-19. J Math Econ. 2021;93: 102489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857053</ArticleId><ArticleId IdType="pubmed">33558783</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http://www.ncbi.nlm.nih.gov/books/NBK554776/. Cited 2024 Apr 15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150360</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccia M. Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: a global analysis. Environ Res. 2022;204: 112314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8560189</ArticleId><ArticleId IdType="pubmed">34736923</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A, Okorie C, Marinkovic A, Ayodele O, Abbasi AF, Prakash S, et al. Measles outbreak in unvaccinated and partially vaccinated children and adults in the United States and Canada (2018–2019): a narrative review of cases. Inquiry. 2019;56:004695801989409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906342</ArticleId><ArticleId IdType="pubmed">31823676</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgakopoulou T, Horefti E, Vernardaki A, Pogka V, Gkolfinopoulou K, Triantafyllou E, et al. Ongoing measles outbreak in Greece related to the recent european-wide epidemic. Epidemiol Infect. 2018;146(13):1692–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9507959</ArticleId><ArticleId IdType="pubmed">30086813</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel M, Lee AD, Clemmons NS, Redd SB, Poser S, Blog D, et al. National update on measles cases and outbreaks — United States, January 1–October 1, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(40):893–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6788396</ArticleId><ArticleId IdType="pubmed">31600181</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Grenfell BT, Mina MJ. Waning immunity and re-emergence of measles and mumps in the vaccine era. Curr Opin Virol. 2020;40:48–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">32634672</ArticleId></ArticleIdList></Reference><Reference><Citation>He H, Chen E, fu, Li Q, Wang Z, Yan R, Fu J, et al. Waning immunity to measles in young adults and booster effects of revaccination in secondary school students. Vaccine. 2013;31(3):533–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23159458</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung AK, Hon K, Leong K, Sergi C. Measles: a disease often forgotten but not gone. Hong Kong Med J. 2018;24(5):512.</Citation><ArticleIdList><ArticleId IdType="pubmed">30245481</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS, Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013;62(RR–04):1–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">23760231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutcliffe PA, Rea E. Outbreak of measles in a highly vaccinated secondary school population. CMAJ. 1996;155(10):1407–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1335111</ArticleId><ArticleId IdType="pubmed">8943928</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardas E. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. J Clin Virol. 1999;13(3):173–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10443793</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley EC, Murphy G, Riley RL. Airborne spread of measles in a suburban elementary school. Am J Epidemiol. 1978;107(5):421–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">665658</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RT, Halsey NA. The clinical significance of measles: a review. Orenstein WA, editor. J Infect Dis. 2004;189(Supplement_1):S4-16.</Citation><ArticleIdList><ArticleId IdType="pubmed">15106083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia N, Feng D, Fang L, Richardus JH, Han X, Cao W, et al. Case fatality of SARS in mainland China and associated risk factors. Trop Med Int Health. 2009;14(s1):21–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169690</ArticleId><ArticleId IdType="pubmed">19508439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DSC, Chan MCH, Wu AK, Ng PC. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J. 2004;80(945):373–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1743054</ArticleId><ArticleId IdType="pubmed">15254300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan-Yeung M, Xu R. SARS: epidemiology. Respirology. 2003;8:s1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169193</ArticleId><ArticleId IdType="pubmed">15018127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip DKM, Lau LLH, Leung NHL, Fang VJ, Chan KH, Chu DKW, et al. Viral shedding and transmission potential of asymptomatic and pauci-symptomatic influenza virus infections in the community. Clin Infect Dis. 2017;64(6):736–42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5967351</ArticleId><ArticleId IdType="pubmed">28011603</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfi C, Spaccarotella C. The outbreak of COVID-19 in Italy. JACC Case Rep. 2020;2(9):1414–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270641</ArticleId><ArticleId IdType="pubmed">32835287</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto SP, Day T, Arino J, Colijn C, Dushoff J, Li M, et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic. Curr Biol. 2021;31(14):R918-29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220957</ArticleId><ArticleId IdType="pubmed">34314723</ArticleId></ArticleIdList></Reference><Reference><Citation>Klepac P, Metcalf CJE, McLean AR, Hampson K. Towards the endgame and beyond: complexities and challenges for the elimination of infectious diseases. Philos Trans R Soc B Biol Sci. 2013;368(1623):20120137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720036</ArticleId><ArticleId IdType="pubmed">23798686</ArticleId></ArticleIdList></Reference><Reference><Citation>Heesterbeek H, Anderson RM, Andreasen V, Bansal S, De Angelis D, Dye C, et al. Modeling infectious disease dynamics in the complex landscape of global health. Science. 2015;347(6227). Available from: https://www.science.org/doi/10.1126/science.aaa4339. Cited 2024 Sept 16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa4339</ArticleId><ArticleId IdType="pmc">PMC4445966</ArticleId><ArticleId IdType="pubmed">25766240</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenfell BT, Pybus OG, Gog JR, Wood JLN, Daly JM, Mumford JA, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science. 2004;303(5656):327–32.</Citation><ArticleIdList><ArticleId IdType="pubmed">14726583</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>